Light-Activated Gels Heal Stubborn Wounds in 95% of Cases

For millions of people with diabetes or severe burns, a simple wound becomes a lifelong nightmare that antibiotics can't fix.

Over 78 percent of chronic wounds develop stubborn bacterial biofilms that resist treatment and often lead to amputation. But scientists have created a new weapon: nanomaterials activated by light that kill infections while helping wounds heal faster.

Researchers led by Raffaele Mezzenga at ETH Zurich engineered a gel using lysozyme, an antimicrobial protein found in egg whites, mixed with a light-absorbing dye. When doctors shine near-infrared light on the wound, the gel heats up and releases the bacteria-fighting protein. Turn off the light, and the gel cools down and stops working.

This precision matters because lysozyme can damage healthy cells too. By activating only where needed, the treatment protects surrounding tissue from harm.

The results in mice and pigs exceeded expectations. The gel eradicated more than 95 percent of bacteria present in wounds, and healing happened significantly faster than with antibiotics or no treatment at all.

The team took things further by adding magnesium ions to the gel. These ions help immune cells switch from fighting inflammation to promoting healing, attacking the problem from two directions at once.

The technology works equally well on medical implants, where bacterial biofilms cause devastating recurring infections. When researchers injected the gel around infected prosthetic joints in mice and activated it with light shone through the skin, it cleared 99 percent of bacteria while preserving bone tissue. This could prevent countless amputations and repeat surgeries.

Another team from China used gold nanoparticles and graphene oxide quantum dots that convert blue light into heat. This dual approach gives doctors multiple tools to fight infections that have stumped medicine for decades.

The Bright Side: While these treatments haven't yet been tested in people, similar light-activated therapies already work safely in humans for treating certain cancers. The path from lab to clinic is well-established, and researchers are optimistic about bringing this breakthrough to patients soon.

Vitaliy Khutoryanskiy, a materials scientist at the University of Reading, notes that diabetic wounds often last a lifetime. That reality could soon change for millions who've lost hope of ever healing.